This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
LRB-1927/1
TJD:all
2017 - 2018 LEGISLATURE
February 23, 2017 - Introduced by Representatives Duchow, Loudenbeck,
Ballweg, Born, E. Brooks, Felzkowski, Kerkman, Krug, Nygren, Ott,
Rohrkaste, Spiros, Steineke and Vos, cosponsored by Senators Darling,
Wanggaard and Olsen. Referred to Committee on Criminal Justice and
Public Safety.
AB83,1,3 1An Act to create 146.343 (1) (e) and 146.346 of the statutes; relating to: sale
2of and research on fetal body parts, final disposition of fetal body parts, cord
3blood banks, and providing a criminal penalty.
Analysis by the Legislative Reference Bureau
Generally, this bill bans the sale of fetal body parts, regulates certain research
on fetal body parts, and requires the final disposition of fetal body parts. This bill
also requires the Department of Health Services to request information from
umbilical cord blood banks on creating a public cord blood collection operation.
Under the bill, fetal body parts are cells, tissue, organs, or other parts of an unborn
child that are obtained after and as the result of an elective abortion, except for
cultured cells and except for cells, tissue, or organs from an aborted fetus if the
abortion occurred before the effective date of the bill.
Current law prohibits a person from knowingly and for valuable consideration
acquiring, receiving, or otherwise transferring a human organ. Current federal law
prohibits a person from knowingly acquiring, receiving, or otherwise transferring,
in interstate commerce, any fetal tissue for valuable consideration. The bill prohibits
any person from knowingly and for valuable consideration acquiring, receiving, or
otherwise transferring a fetal body part and from knowingly using, for research, a
fetal body part that is provided or received for valuable consideration. The bill
prohibits knowingly acquiring or receiving any fetal body part for research from a
for-profit entity, an abortion clinic, or an entity that has as its primary function
obtaining fetal tissue for sale. The bill prohibits the altering of the timing, method,

or procedures used to terminate a woman's pregnancy solely for the purpose of
obtaining a fetal body part for research. The bill also prohibits a woman's attending
physician who obtains a fetal body part from being involved in performing research
on the fetal body part.
A person who uses or receives a fetal body part for research is required by the
bill to obtain written documentation that the entity that provided the fetal body part
did not obtain the fetal body part for valuable consideration and to maintain that
written documentation for seven years. Before using a fetal body part in research,
an institutional review board must review the documentation from the entity that
provided the fetal body part to determine that informed consent was obtained in
accordance with federal law and that other requirements specified in the bill are met.
The bill also exempts from criminal or civil liability or charges of unprofessional
conduct a person who conscientiously objects to participation in research utilizing a
fetal body part that violates that person's moral or religious beliefs.
The bill requires that a physician who performs or induces an abortion in this
state arrange for the final disposition of the fetal body parts. Final disposition, under
the bill, means the disposition of fetal body parts by burial, interment, entombment,
cremation, or incineration.
The people of the state of Wisconsin, represented in senate and assembly, do
enact as follows:
AB83,1 1Section 1. 146.343 (1) (e) of the statutes is created to read:
AB83,2,32 146.343 (1) (e) “Principal prenatal health care provider" means a nurse,
3nurse-midwife, or physician who is the primary prenatal health care provider.
AB83,2 4Section 2. 146.346 of the statutes is created to read:
AB83,2,5 5146.346 Fetal body parts; research. (1) Definitions. In this section:
AB83,2,96 (a) “Fetal body part" means a cell, tissue, organ, or other part of an unborn
7child, as defined in s. 939.75 (1), that is obtained after and as a result of an elective
8abortion, as defined in s. 253.10 (2) (a). “Fetal body part" does not include any of the
9following:
AB83,2,1010 1. Cultured cells.
AB83,3,3
12. Cells, tissue, or organs from an aborted fetus if the abortion, as defined in
2s. 253.10 (2) (a), occurred before the effective date of this subdivision .... [LRB inserts
3date].
AB83,3,54 (b) “Final disposition" means the disposition of fetal body parts by burial,
5interment, entombment, cremation, or incineration.
AB83,3,86 (c) “Research" means a systematic investigation, including research,
7development, testing, and evaluation, designed to develop or contribute to
8generalizable knowledge.
AB83,3,109 (d) “Valuable consideration" has the meaning given in 42 USC 289g-2 (e) (3)
10as amended to January 1, 2017.
AB83,3,12 11(2) Prohibitions; research requirements. (a) No person may knowingly and
12for valuable consideration acquire, receive, or otherwise transfer a fetal body part.
AB83,3,1413 (b) No person may knowingly use, for research, a fetal body part that is
14provided or received for valuable consideration.
AB83,3,1715 (c) No person may knowingly acquire or receive any fetal body part for research
16from a for-profit entity, an abortion clinic, or an entity that has as its primary
17function obtaining fetal tissue for sale.
AB83,3,2018 (d) No person may alter the timing, method, or procedures used to terminate
19a woman's pregnancy solely for the purpose of obtaining a fetal body part for
20research.
AB83,3,2221 (e) A woman's attending physician who obtains a fetal body part may not be
22involved in performing research on the fetal body part.
AB83,4,223 (f) Any person who uses or receives any fetal body part for research shall obtain
24written documentation from the entity that provided the fetal body part that certifies
25that the entity did not obtain the fetal body part for valuable consideration. The

1person who uses or receives the fetal body part for research shall maintain that
2written documentation from the entity for at least 7 years.
AB83,4,73 (g) Before the use of any fetal body part for research, an institutional review
4board shall review the written documentation from the entity that provided the fetal
5body part to determine that informed consent for research using the fetal body part
6was obtained in accordance with 45 CFR 46.116 and, if applicable, 42 USC 289g-1
7and that all of the following requirements are met:
AB83,4,118 1. The consent of the woman for the abortion, as defined in s. 253.10 (2) (a), is
9obtained before requesting or obtaining her consent for donation of the fetal body
10part for research in accordance with 45 CFR 46.116 and, if applicable, 42 USC
11289g-1
.
AB83,4,15122. The woman donating the fetal body part is informed, in accordance with 45
13CFR 46.116
and, if applicable, 42 USC 289g-1, of any known medical risks to her or
14any risks to her privacy that might be associated with the donation of a fetal body
15part and of any similar risks that are associated with her medical care.
AB83,4,2416 (h) This subsection does not apply to use of a fetal body part for diagnostic or
17remedial tests, procedures, or observations that have the sole purpose of determining
18the life or health of the unborn child in order to provide that information to the
19mother or preserving the life or health of the child, unborn child, or the child's
20mother. Notwithstanding pars. (a) to (c), a person is not guilty of violating this
21section if the person is developing pharmaceutical products or paying or receiving a
22payment for an existing pharmaceutical product. Nothing in this section may be
23construed as restricting access to health care, to prescription drugs or devices, or to
24other pharmaceutical products.
AB83,5,3
1(3) Final disposition. (a) Notwithstanding sub. (2) (a) to (c), a physician who
2performs or induces an abortion, as defined in s. 253.10 (2) (a), in this state shall
3arrange for the final disposition of fetal body parts resulting from the abortion.
AB83,5,64 (b) Notwithstanding sub. (2) (a) to (c), a person is not guilty of violating this
5section if the person is acting exclusively in furtherance of final disposition of a fetal
6body part.
AB83,5,9 7(4) Conscience. No person may be held criminally or civilly liable or charged
8with unprofessional conduct for conscientiously objecting to participation in
9research utilizing a fetal body part that violates a person's moral or religious belief.
AB83,5,11 10(5) Penalty. Any person who violates this section is subject to a fine not to
11exceed $50,000 or imprisonment not to exceed 9 months, or both.
AB83,3 12Section 3 . Nonstatutory provisions.
AB83,5,1313 (1) Information on establishing public cord blood collection operation.
AB83,5,2014 (a) Before January 1, 2018, the department of health services shall request
15information from at least one umbilical cord blood bank regarding the establishment
16of a public cord blood collection operation within the state to collect, transport,
17process, and store cord blood from residents of the state for therapeutic and research
18purposes. The department of health services shall include in the request for
19information questions eliciting the umbilical cord blood bank's ability to do all of the
20following:
AB83,5,22 211. Establish and operate one or more collection sites within the state to collect
22a specified target number of cord blood units.
AB83,5,24 232. Implement collection procedures designed to collect cord blood units that
24reflect the state's racial and ethnic diversity.
AB83,6,4
13. Establish public cord blood collection operations no later than 6 months after
2executing a contract with the department of health services unless the umbilical cord
3blood bank is unable to negotiate any necessary contracts related to the collection
4sites within that time.
AB83,6,7 54. Participate in the National Cord Blood Coordinating Center or a similar
6national cord blood inventory that lists cord blood units in a manner that assures
7maximum opportunity for use.
AB83,6,10 85. Establish and operate a program that provides cord blood units for research
9and agree to provide cord blood units that are unsuitable for therapeutic use to
10researchers located within the state at no cost to the researcher.
AB83,6,12 116. Maintain national accreditation with an accrediting organization that is
12recognized by the federal health resources and services administration.
AB83,6,1713 (b) Before April 1, 2018, the department of health services shall submit a
14summary of the responses to the request for information under paragraph (a) and
15any recommendations developed from the responses to the governor and to the
16appropriate standing committees of the legislature under section 13.172 (3) of the
17statutes.
AB83,6,1818 (End)
Loading...
Loading...